Neuro42
About:
Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.
Website: http://neuro42.ai/
Top Investors: Zepp, National Institute of Neurological Disorders and Stroke, Fred Moll, M.D, Shangbay Capital, Zynext Ventures
Description:
Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.
Total Funding Amount:
$28.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2020-01-01
Contact Email:
hello(AT)neuro42.com
Founders:
Amit Vohra, Michael Bartholomew, Nikhil Sadhwani
Number of Employees:
11-50
Last Funding Date:
2024-08-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai